Alcohol and Iron

 

 Buy Article Permissions and Reprints

Iron in its free ferrous and ferric states may serve as a physiological regulator of normal intracellular functions but can be a double-edged sword when linked to several pathways of cellular toxicity. In particular, oxidative stress-induced cytotoxicity leading to both necrosis and apoptosis (so-called necrapoptosis) may be promoted by increased intracellular free iron. When hepatocyte iron accumulates to excess in clinical alcohol abuse or in an experimental, combined model of iron and alcohol hepatotoxicity, there is evidence for synergy among the putative pathways of oxidative stress. Just how excess hepatocyte iron accumulates in alcohol excess is unknown, but when the usual safe harbor for intracellular iron, namely the endosomal-lysosomal compartment, is compromised, it becomes a potent source of free, chelatable pro-oxidant iron. In this regard excess iron in alcohol-induced liver damage and alcohol excess in iron-overload disease are powerful cocktails promoting subcellular organelle damage leading to cell death and fibrogenesis. In some experimental circumstances, only the combined insults of both alcohol and iron overload are capable of inducing cell injury and fibrogenesis. There are clinical examples for such relative resistance to each hepatotoxin presented to the liver in isolation that lend support to this concept of synergy of pro-oxidant pathways of liver injury.

REFERENCES

• 1 Britton R S. Metal-induced hepatoxicity.  Semin Liver Dis. 1996;  16 3-12
  PubMedGoogle Scholar
• 2 Niederau C, Fischer R, Purschel A et al.. Long-term survival in patients with hereditary hemochromatosis.  Gastroenterology. 1996;  110 1107-1119
  CrossrefPubMedGoogle Scholar
• 3 Bacon B R, Britton R S. The pathology of hepatic iron overload: A free radical-mediated process?.  Hepatology. 1990;  11 127-137
  PubMedGoogle Scholar
• 4 Pietrangelo A. Metals, oxidative stress, and hepatic fibrogenesis.  Semin Liver Dis. 1996;  16 13-30
  Article in Thieme ConnectPubMedGoogle Scholar
• 5 Pietrangelo A. Mechanisms of liver injury and fibrosis due to iron and copper. American Association for the Study of Liver Diseases (AASLD) Review Course October 2003: 53-58
  Google Scholar
• 6 Bacon B R, Tavill A S, Brittenham G M et al.. Hepatic lipid peroxidation in vivo in rats with chronic iron overload.  J Clin Invest. 1983;  71 429-439
  PubMedGoogle Scholar
• 7 Pietrangelo A, Gualdi R, Casalgrandi G et al.. Enhanced hepatic collagen type I mRNA expression into fat-storing cells in a rodent model of hemochromatosis.  Hepatology. 1994;  19 714-721
  CrossrefPubMedGoogle Scholar
• 8 Pietrangelo A, Gualdi R, Casalgrandi G et al.. Molecular and cellular aspects of iron-induced hepatic cirrhosis in rodents.  J Clin Invest. 1995;  95 1824-1831
  PubMedGoogle Scholar
• 9 Seymour C A, Peters T J. Organelle pathology in primary and secondary haemochromatosis with special reference to lysosomal changes.  Br J Haematol. 1978;  40 239-253
  PubMedGoogle Scholar
• 10 Selden C, Owen M, Hopkins J MP et al.. Studies on the concentration and intracellular localization of iron proteins in liver biopsy specimens from patients with iron overload with special reference to their role in lysosomal disruption.  Br J Haematol. 1980;  44 593-603
  PubMedGoogle Scholar
• 11 O'Connell M J, Ward R J, Baum H, Peters T J. The role of iron in ferritin and haemosiderin-mediated lipid peroxidation in lysosomes.  Biochem J. 1985;  229 135-139
  PubMedGoogle Scholar
• 12 Hultcrantz R, Ahlberg J, Glaumann H. Isolation of two lysosomal populations from iron-overload rat liver with different iron concentration and proteolytic activity.  Virchows Arch [B]. 1984;  47 55-65
  PubMedGoogle Scholar
• 13 Myers B M, Prendergast F G, Holman R et al.. Alterations in structure, physicochemical properties, and pH of hepatocyte lysosomes in experimental iron overload.  J Clin Invest. 1991;  88 1207-1215
  PubMedGoogle Scholar
• 14 Seymour C A, Peters T J. Organelle pathology in primary and secondary haemochromatosis with special reference to lysosomal changes.  Br J Haematol. 1978;  40 239-253
  PubMedGoogle Scholar
• 15 Britton R S, Ramm G A, Olynyk J et al.. Pathophysiology of iron toxicity.  Adv Exp Med Biol. 1994;  356 239-253
  PubMedGoogle Scholar
• 16 Park C H, Bacon B R, Brittenham G M, Tavill A S. Pathology of dietary carbonyl iron overload in rats.  Lab Invest. 1987;  57 555-563
  PubMedGoogle Scholar
• 17 Rauen U, Petrat F, Sustmann R, de Groon H. Iron-induced mitochondrial permeability transition in cultured hepatocytes.  J Hepatol. 2004;  40 607-615
  CrossrefPubMedGoogle Scholar
• 18 LeMasters J L. Rusty notions of cell injury.  J Hepatol. 2004;  40 696-698
  CrossrefPubMedGoogle Scholar
• 19 Tavill A S, Bacon B R. Hemochromatosis: how much iron is too much?.  Hepatology. 1986;  6 142-145
  PubMedGoogle Scholar
• 20 Summers K M, Halliday J W, Powell L W. Identification of homozygous hemochromatosis subjects by measurement of hepatic iron index.  Hepatology. 1990;  12 20-25
  CrossrefPubMedGoogle Scholar
• 21 Bassett M L, Halliday J W, Powell L W. Value of hepatic iron measurements in early hemochromatosis and determination of the critical iron level associated with fibrosis.  Hepatology. 1986;  6 24-29
  PubMedGoogle Scholar
• 22 Sallie R, Reed W D, Shilkin K B. Confirmation of the efficacy of the hepatic iron index in differentiating genetic haemochromatosis from alcoholic liver disease complicated by alcoholic haemosiderosis.  Gut. 1991;  32 207-210
  PubMedGoogle Scholar
• 23 Beaton M, Guyader D, Deugnier Y et al.. Noninvasive prediction of cirrhosis in C282Y-linked hemochromatosis.  Hepatology. 2002;  36 673-678
  CrossrefPubMedGoogle Scholar
• 24 Morrison E D, Brandhagen D J, Phatak P D et al.. Serum ferritin levels predict advanced hepatic fibrosis among U. S. patients with phenotypic hemochromatosis.  Ann Intern Med. 2003;  138 627-633
  PubMedGoogle Scholar
• 25 Pietrangelo A, Rocchi E, Schiaffonoti L et al.. Liver gene expression during chronic dietary iron overload in rats.  Hepatology. 1990;  11 798-804
  PubMedGoogle Scholar
• 26 Pietrangelo A, Borella F, Casalgrandi G et al.. Antioxidant activity of silybin in vivo during long-term iron overload in rats.  Gastroenterology. 1995;  109 1941-1949
  PubMedGoogle Scholar
• 27 Houglum K, Grant A R, Crawford D HG et al.. Excess iron induces hepatic oxidative stress and transforming growth factor B1 in genetic hemochromatosis.  Hepatology. 1997;  26 605-610
  CrossrefPubMedGoogle Scholar
• 28 Parola M, Robino G, Dianzani M U. 4-hydroxy-2, 3-alkenals as molecular mediators of oxidative stress in the pathogenesis of liver fibrosis.  Int J Mol Med. 1999;  4 425-432
  PubMedGoogle Scholar
• 29 Zhou X Y, Tomatsu S, Fleming R E et al.. HFE gene knockout produces mouse model of hereditary hemochromatosis.  Proc Natl Acad Sci USA. 1998;  95 2492-2497
  CrossrefPubMedGoogle Scholar
• 30 Bell H, Skinningsrud A, Raknerud N, Try K. Serum ferritin and transferrin saturation in patients with chronic alcoholic and non-alcoholic liver disease.  J Intern Med. 1994;  236 315-322
  PubMedGoogle Scholar
• 31 Sabesin S M, Thomas L B. Parenchymal siderosis in patients with preexisting portal cirrhosis. A pathologic entity simulating idiopathic and transfusional hemochromatosis.  Gastroenterology. 1964;  46 477-485
  PubMedGoogle Scholar
• 32 Powell L W. Normal human iron storage and its relation to ethanol consumption.  Australas Ann Med. 1966;  15 110-115
  PubMedGoogle Scholar
• 33 Lundvall O, Weinfeld A, Lundin P. Iron stores in alcohol abusers.  Acta Med Scand. 1969;  185 259-269
  PubMedGoogle Scholar
• 34 Jacobovits A, Morgan M Y, Sherlock S. Hepatic siderosis in alcoholics.  Dig Dis Sci. 1979;  24 305-310
  CrossrefPubMedGoogle Scholar
• 35 MacDonald R A. Primary hemochromatosis: inherited or acquired?.  Prog Hematol. 1966;  5 324-353
  PubMedGoogle Scholar
• 36 Simon M, Bourel M, Genetet B, Fauchet R. Idiopathic hemochromatosis. Demonstration of recessive transmission and early detection by family HLA typing.  N Engl J Med. 1977;  297 1017-1021
  PubMedGoogle Scholar
• 37 Simon M, Bourel M, Genetet B et al.. Idiopathic hemochromatosis and iron overload in alcoholic liver disease: differentiation by HLA phenotype.  Gastroenterology. 1977;  73 655-658
  PubMedGoogle Scholar
• 38 Simon M, Alexandre J L, Bourel M et al.. Heredity of idiopathic haemochromatosis: a study of 106 families.  Clin Genet. 1977;  11 327-341
  PubMedGoogle Scholar
• 39 Simon M, Bourel M, Genetet B, Fauchet R. Idiopathic haemochromatosis: demonstration of recessive transmission and early detection by family HLA typing.  N Engl J Med. 1977;  297 1017-1022
  PubMedGoogle Scholar
• 40 Finch S C, Finch C A. Idiopathic hemochromatosis, an iron storage disease. A. Iron metabolism in hemochromatosis.  Medicine. 1955;  34 381-430
  CrossrefPubMedGoogle Scholar
• 41 Milder M S, Cook J D, Stray S, Finch C A. Idiopathic hemochromatosis, an interim report.  Medicine (Baltimore). 1980;  59 34-49
  PubMedGoogle Scholar
• 42 Powell L W. Iron storage in relatives of patients with haemochromatosis and in relatives of patients with alcoholic cirrhosis and haemochromatosis. A comparative study of 27 families.  Q J Med. 1965;  34 427-442
  PubMedGoogle Scholar
• 43 Beutler E, Felitti V, Koziol J A et al.. Penetrance of 845G→A (C282Y) HFE hereditary haemochromatosis mutation in the USA.  Lancet. 2002;  359 211-218
  CrossrefPubMedGoogle Scholar
• 44 LeSage G D, Baldus W P, Fairbanks V F et al.. Hemochromatosis: genetic or alcohol-induced?.  Gastroenterology. 1983;  84 1471-1477
  PubMedGoogle Scholar
• 45 Cederbaum A I. Oxygen radical generation by microsomes: role of iron and implications for alcohol metabolism and toxicity.  Free Radic Biol Med. 1989;  7 559-567
  CrossrefPubMedGoogle Scholar
• 46 Ekstrom G, Ingelman-Sundberg M. Rat liver microsomal NADPH-supported oxidase activity and lipid peroxidation dependent on ethanol-inducible cytochrome P450 (P-459 IIE1).  Biochem Pharmacol. 1989;  38 1313-1319
  CrossrefPubMedGoogle Scholar
• 47 Morimoto M, Hagbjork A L, Nanji A A et al.. Role of cytochrome P450 2E1 in alcoholic liver disease pathogenesis.  Alcohol. 1993;  10 459-464
  CrossrefPubMedGoogle Scholar
• 48 Ekstrom G, Cronholm T, Ingelman-Sundberg M. Hydroxyl-radical production of ethanol oxidation by liver microsomes isolated from ethanol treated rats.  Biochem J. 1986;  233 755-761
  PubMedGoogle Scholar
• 49 Niemela O, Parkkila S, Britton R S et al.. Hepatic lipid peroxidation in hereditary hemochromatosis and alcoholic liver injury.  J Lab Clin Med. 1999;  133 451-460
  CrossrefPubMedGoogle Scholar
• 50 Bacon B, Tavill A. Role of the liver in normal iron metabolism.  Semin Liver Dis. 1984;  4 181-192
  PubMedGoogle Scholar
• 51 Reif D W. Ferritin as a source of iron for oxidative damage.  Free Radic Biol Med. 1992;  12 417-427
  CrossrefPubMedGoogle Scholar
• 52 Shaw S. Lipid peroxidation, iron mobilization and radical generation induced by alcohol.  Free Radic Biol Med. 1989;  7 541-547
  CrossrefPubMedGoogle Scholar
• 53 French S W. The mechanism of organ injury in alcoholics: implications for therapy.  Alcohol Alcohol Suppl. 1991;  1 57-63
  PubMedGoogle Scholar
• 54 Sanchez J, Casas M, Rama R. Effect of chronic ethanol administration on iron metabolism in the rat.  Eur J Haematol. 1988;  41 321-325
  PubMedGoogle Scholar
• 55 Fairweather-Tait S J, Southon S, Piper Z. The effect of alcoholic beverages on iron and zinc metabolism in the rat.  Br J Nutr. 1988;  60 209-215
  CrossrefPubMedGoogle Scholar
• 56 Sadrzadeh S MH, Nanji A A, Price P L. The oral iron-chelator, 1,2-dimethyl-3-hydroxypyrid-4-one reduces hepatic-free iron, lipid peroxidation and fat accumulation in chronically ethanol-fed rats.  J Pharmacol Exp Ther. 1994;  269 632-636
  PubMedGoogle Scholar
• 57 Hultcrantz R, Bissell D M, Roll F J. Iron mediates production of a neutrophil chemoattractant by rat hepatocytes metabolizing ethanol.  J Clin Invest. 1991;  87 45-49
  PubMedGoogle Scholar
• 58 Tsukamoto H, Towner S J, Ciafalo L M et al.. Ethanol-induced liver fibrosis in rats fed high fat diet.  Hepatology. 1986;  6 814-822
  CrossrefPubMedGoogle Scholar
• 59 Tsukamoto H, Matsuoka M, French S W. Experimental models of hepatic fibrosis.  Semin Liver Dis. 1990;  10 56-65
  PubMedGoogle Scholar
• 60 Tsukamoto H, Horne W, Kamimura S et al.. Experimental liver cirrhosis induced by alcohol and iron.  J Clin Invest. 1995;  96 620-630
  CrossrefPubMedGoogle Scholar
• 61 Adams P C, Chakrabarti S. Genotypic/phenotypic correlations in genetic hemochromatosis: evolution of diagnostic criteria.  Gastroenterology. 1998;  114 319-323
  PubMedGoogle Scholar
• 62 Powell L W, Summers K M, Board P G et al.. Expression of hemochromatosis in homozygous subjects. Implication for early diagnosis and prevention.  Gastroenterology. 1990;  98 1625-1632
  PubMedGoogle Scholar
• 63 Adams P C, Frei J V, Bradley C, Lam D. Hepatic iron and iron absorption in hemochromatosis.  Clin Invest Med. 1990;  13 256-258
  PubMedGoogle Scholar
• 64 Cotler S, Bronner M, Press D et al.. End-stage liver disease without hemochromatosis associated with elevated hepatic iron index.  J Hepatol. 1998;  29 257-262
  CrossrefPubMedGoogle Scholar
• 65 Feder J N, Gnirke A, Thomas W et al.. A novel MHC class I-like gene mutation in patients with hereditary haemochromatosis.  Nat Genet. 1996;  13 399-408
  CrossrefPubMedGoogle Scholar
• 66 Bacon B R, Powell L W, Adams P C et al.. Molecular medicine and hemochromatosis: at the crossroads.  Gastroenterology. 1999;  116 193-207
  PubMedGoogle Scholar
• 67 Bacon B R, Olynyk J K, Brunt E M et al.. HFE genotype in patients with hemochromatosis and other liver diseases.  Ann Intern Med. 1999;  130 953-962
  CrossrefPubMedGoogle Scholar
• 68 Adams P C, Agnew S. Alcoholism in hereditary hemochromatosis revisited: prevalence and clinical consequences among homozygous siblings.  Hepatology. 1996;  23 724-727
  CrossrefPubMedGoogle Scholar
• 69 Fletcher L, Dixon J, Purdie D et al.. Excess alcohol greatly increases the prevalence of cirrhosis in hereditary hemochromatosis.  Gastroenterology. 2002;  122 281-289
  CrossrefPubMedGoogle Scholar
• 70 Ioannou G N. The effect of alcohol consumption on the prevalence of iron overload, iron deficiency, and iron deficiency anemia.  Gastroenterology. 2004;  126 1293-1301
  CrossrefPubMedGoogle Scholar
• 71 Regoeczi E, Chindemi P A, Debanne M T. Transferrin glycans: a possible link between alcoholism and alcoholic siderosis.  Alcohol Clin Exp Res. 1984;  8 287-292
  PubMedGoogle Scholar
• 72 Beguin Y, Bergamschi G, Huebers H, Finch C A. The behavior of asialotranferrin-iron in the rat.  Am J Hematol. 1988;  29 204-210
  PubMedGoogle Scholar
• 73 Rouach H, Houze P, Gentil M et al.. Effects of acute ethanol administration on the uptake of [59]Fe-labeled transferrin by rat liver and cerebellum.  Biochem Pharmacol. 1994;  47 1835-1841
  CrossrefPubMedGoogle Scholar
• 74 Chapman R W, Morgan M Y, Boss A M, Sherlock S. Acute and chronic effects of alcohol on iron absorption.  Dig Dis Sci. 1983;  28 321-327
  CrossrefPubMedGoogle Scholar
• 75 Bonkovsky H L, Banner B F, Lambrecht R W, Rubin R B. Iron in liver diseases other than hemochromatosis.  Semin Liver Dis. 1996;  16 65-82
  PubMedGoogle Scholar
• 76 Milman N, Graudal N, Hegnhoj J et al.. Relationships among serum iron status markers, chemical and histochemical liver iron content in 117 patients with alcohol and non-alcohol hepatic disease.  Hepatogastroenterology. 1994;  41 20-24
  PubMedGoogle Scholar
• 77 Grace N D, Greenberg M S. Phlebotomy in the treatment of iron overload: a controlled trial (a preliminary report.)  Gastroenterology. 1971;  60 744 (Abst)
  PubMedGoogle Scholar
• 78 MacPhail A P, Simon M O, Torrance J D et al.. Changing patterns of dietary iron overload in black South Africans.  Am J Clin Nutr. 1979;  32 1272-1278
  PubMedGoogle Scholar
• 79 Issacson C, Seftel H, Keeley K J, Bothwell T H. Siderosis in the Bantu. The relationship between iron overload and cirrhosis.  J Lab Clin Med. 1961;  58 845-853
  PubMedGoogle Scholar
• 80 Gordeuk V R, Mukabi J, Hasstedt J et al.. Iron overload in Africa: interaction between a gene and dietary iron content.  N Engl J Med. 1992;  326 95-100
  CrossrefPubMedGoogle Scholar
• 81 Bacon B R, Farahvash M J, Janney C G, Neuschwander-Tetri B A. Nonalcoholic steatohepatitis: an expanded clinical entity.  Gastroenterology. 1994;  107 1103-1109
  PubMedGoogle Scholar
• 82 George D K, Goldwurm S, MacDonald G A et al.. Increased hepatic iron concentration in nonalcoholic steatohepatitis is associated with increased fibrosis.  Gastroenterology. 1998;  114 311-318
  CrossrefPubMedGoogle Scholar
• 83 Bonkovsky H L, Jawaid Q, Tortorelli K et al.. Non-alcoholic steatohepatitis and iron: increased prevalence of mutations of the HFE gene in non-alcoholic steatohepatitis.  J Hepatol. 1999;  31 421-429
  CrossrefPubMedGoogle Scholar
• 84 Rocchi E, Gilbertini P, Cassanelli M et al.. Serum ferritin in the assessment of liver iron overload and iron removal therapy in porphyria cutanea tarda.  J Lab Clin Med. 1986;  107 36-42
  PubMedGoogle Scholar
• 85 Rocchi E, Gilbertini P, Cassanelli M et al.. Liver iron overload and desferrioxamine treatment of porphyria cutanea tarda.  Dermatologica. 1991;  182 27-31
  PubMedGoogle Scholar
• 86 Edwards C Q, Griffen L M, Goldgar D E et al.. HLA-linked hemochromatosis alleles in sporadic porphyria cutanea tarda.  Gastroenterology. 1989;  97 972-981
  PubMedGoogle Scholar
• 87 Roberts A G, Whatley S D, Morgan R R et al.. Increased frequency of the haemochromatosis Cys282Tyr mutation in sporadic porphyria cutanea tarda.  Lancet. 1997;  349 321-323
  CrossrefPubMedGoogle Scholar
• 88 Bonkovsky H L. Iron as a comorbid factor in chronic viral hepatitis.  Am J Gastroenterol. 2002;  97 1-3
  CrossrefPubMedGoogle Scholar
• 89 Tung B Y, Emond M J, Bronner M P et al.. Hepatitis C, iron status, and disease severity: relationship with HFE mutations.  Gastroenterology. 2003;  124 318-326
  CrossrefPubMedGoogle Scholar
• 90 Pietrangelo A. Hemochromatosis gene modifies course of hepatitis C viral infection.  Gastroenterology. 2003;  124 1509-1523
  CrossrefPubMedGoogle Scholar

Anthony S TavillM.D. 

Division of Gastroenterology, MetroHealth Medical Center

2500 MetroHealth Drive

Cleveland, OH 44109